Stay updated on Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new page revision v3.6.6 was added and the previous revision v3.6.5 was removed, indicating a small update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-08-29T14:09:05.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, signaling a newer version of the page rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-08-08T12:31:06.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Updated the page revision label from v3.6.3 to v3.6.4, signaling a minor metadata update to the page. This change does not alter study details, eligibility, endpoints, or results.
    Difference
    0.1%
    Check dated 2026-07-25T13:27:14.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, indicating a backend/frontend update. There is no evident change to the study details, enrollment criteria, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-07-04T14:35:32.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2 on the page, indicating a minor document update.
    Difference
    0.1%
    Check dated 2026-06-27T12:18:22.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Enrollment status updated to indicate recruitment has ended. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, with the revision label changed to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T17:04:26.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.